"When Loren Peterson moved ZyStor Therapeutics from St. Louis, Mo., to Milwaukee in the early 2000s, he had trouble finding other health care and biotechnology startups to keep him company.

“It was pretty much a desert,” recalled Peterson, who sold ZyStor and its line of enzyme replacement therapies to BioMarin Pharmaceutical Inc. in 2010.

Today, Milwaukee’s once-arid life sciences landscape is sprouting more ideas and emerging companies. It’s a trend that was on display Thursday at Milwaukee’s University Club during a pitch event that featured five promising health-tech ideas as well as two innovations in advanced materials."

Click here to view the Journal Sentinel's article.

Related People

Download vCard
Preview Attorney's Biography
Greg Lynch is a partner in the firm’s Transactional Practice Group and Energy Industry Group. He also is the Co-Founder of the firm’s Venture Best^TMventure practice. His principal experience includes early-stage company formation, angel and venture capital financing, public and private placement of securities, stock option and equity incentive plans, and more.
Gregory J. Lynch
gjlynch@michaelbest.com
T.608.283.2240

Related Industry

Life Sciences

Explore our Microsites

Blogs

Partner & Employee Best Access First time users must log in to Best Access via the Virtual Environment, not via this link.

News

Lynch quoted in "Milwaukee's Life Sciences Landscape is Sprouting"

Related People

Related Industry

Related Practices

Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.